Mary Miller - Chief Legal Officer at Acrivon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Legal Officer
Issuer Symbol
ACRV on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mary Miller since 08 Jan 2025

Holdings reported by Mary Miller for Acrivon Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 34,555 $77,403 $2.24 14 Nov 2025 Direct
Stock Option (Right to Buy) 15,616 01 Apr 2025 Direct Common Stock

Transactions reported by Mary Miller for Acrivon Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.